Current Topics in iPSCs Technology

Screening Transplantation Regeneration Infertility Model Ethics Aging 3D Biomaterial Classification Genomics Guidelines Human genetics Informed Consent. Insulin resistance. Nucleic acids Reproduction Differentiation Pancreas Myogenesis Mood Disorders In vitro Policy Tissue engineering Regulation DNA damage Metabolic syndrome Stem cells Toxicology Bioengineering Arrhythmia Oxidative stress Embryonic stem cells Cell cycle Lung Proteomics Attention-deficit-hyperactivity disorder Cystic fibrosis Pharmacogenomics Mesenchyme Brugada syndrome Methylation Ovary Rejuvenation Therapy Biogenesis Cell proliferation Drug Screening Histones Regenerative Medicine Seizures Testis Induced Pluripotent Stem Cells Mesenchymal stem cells Metabolomics Pluripotent Stem Cells Epigenetics Epigenomics Genomic Instability Intellectual Disability Autism spectrum disorder Personalized medicine Gene Editing Exosomes Cellular Reprogramming Tumorigenesis Sudden cardiac death Patch clamp Next generation sequencing Scaffold Type 2 diabetes Hepatotoxicity Reprogramming Epigenetic memory IPSCs Clinical application Cardiomyocytes Reentry High-throughput RNA sequencing Therapeutic agent Chromosomal Aberrations High-throughput screening Extracellular vesicles Neurotoxicity H2AX Cardiometabolic disease Chimera Saccular Drug-Delivery Channelopathy ER stress Chromosomal abnormalities Transcriptomics Nanofiber Stem cell differentiation Calcium imaging Synthetic polymers Sodium channel Disease Modeling Biliary tree 3D printing Nephrotoxicity Cell therapy Nicotinic Acetylcholine Receptors Organ-on-chip Cardiovascular Disease CKD Data Integration MiRNAs Oocyte Human subjects Vascularization IPS cells Biofabrication Copy number variations Assisted reproductive technologies Somatic mutations FDA Intestine Action potential Microvesicles Natural Polymers Cardiotoxicity Genome-wide association studies EMA Cell-Free Therapy Niche ESRD Secretome SCN5A Antagomirs Acetylation Genetic basis 15q13.3 microdeletions 15q13.3 microduplications 3D culture Aging clocks Alveolar type 1 cell Alveolar type 2 cell alveolarization Assembloid Beneficial therapeutic effect Bioimplant Basal progenitor cell Canalicular CACNB2Cardiac arrest CFTR modulators Anterior foregut endoderm Apoptotic bodies Club (Clara) cell CHRNA7Copy number variation ciliated cell Developmental Toxicity Brain organoid Erythromycin DNA damage response (DDR)Embryonic stem cells (ESCs)Genomic instability Clustered regularly interspaced short palindromic repeats (CRISPRs)Drug-related adverse effect Differentiation protocols goblet cell Expression quantitative trait loci (eQTLs)Genome-wide association study (GWAS)Genomics HiPSC apoptosis Human induced pluripotent stem cells (hiPSCs)Hydrogel Definitive endoderm Gonadal development Heart organoid Directed differentiation DNA methylation clocks Human induced pluripotent stem cell (hiPSC)Multiomics Institutional review board (IRB)Oversight hiPSC cohort HiPSC glycolysis Human germ cell development Human iPSC-CMs Induced pluripotency iPSC-derived cortical neurons Liver organoid Mesodermal specification Paracrine mechanism noncoding DNA Nkx2.1Pseudoglandular Human cardiomyocytes OTUD7A HiPSC overgrowth HiPSC proteome Pharmaceutical discovery In vitro arrhythmogenicity In vitro gametogenesis Point mutations Primordial germ cell Receptor-ligand Risk loci HiPSC extended culture HiPSC metabolic state Human based Surface markers species-specific Induced pluripotent stem cells (iPSCs)Pluripotent stem cells (PSCs)Replication Inherited cardiac disease Sodium Current Spermatogonial stem cell Kidney organoid Pluripotency markers MyoD1Myofiber repair Myogenic differentiation protocols miRNA mimics Physiological or disease traits Research donor